Biomarkers Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
BIOMARKERS MARKET ANALYSIS

• Biomarkers Market, by Product Type (Biomarker
  Test Kits, and Biomarker Analyzers), By Disease
  Indication (Cancer, Cardiovascular Disorder,
  Infectious Disease, Neurological Disorder,
  Immunological Disorder and Others), by
  Application (Diagnosis, Drug Discovery and
  Development, and Others ), By End User
  (Hospitals, Research Laboratories, Ambulatory
  Surgical Centers, and Diagnostic Laboratories),
  and by Geography - Global Forecast to 2025.
• The biomarkers market is estimated to be valued
  at US 29,518.2 Mn in 2017 and is expected to
  witness a robust CAGR of 13.6 during the
  forecast period (2017-2025).

3
Industry Insights

• Biomarkers are gaining significant traction in
  product development and treatment of disorders
  related to chromosome structure, Turner syndrome,
  Down syndrome, Patau syndrome, Edwardss
  syndrome, and others, which is propelling demand
  for biomarkers. For instance, in February 2018,
  FDA granted marketing authorization to Banyan
  Biomarkers, Inc. for the first diagnostic blood
  test for traumatic brain injury, Banyan BTI.
  Therefore, introduction of such innovative
  diagnostic tools for various disease indication
  is projected to fuel growth of the Biomarkers
  Market over the forecast period.
• Moreover, pharmaceutical companies have started
  outsourcing the complex bio analysis not only to
  cut down costs, however, to take advantage of
  specialized expertise to improve efficiency in
  drug development process. For instance, in March
  2018, the SenzaGen signed a key license agreement
  with Burlesson Research Technologies, Inc.,
  (BRT)a contract research organization in the
  U.S., specializing in immunotoxicology. This
  agreement, will provide BRTs 'GARD' to a broader
  market. GARD is a group of tests for assessing
  chemical sensitizers, where the test uses genetic
  biomarkers for over 200 genes, which cover an
  entire immune reaction and are relevant to
  predicting the risk of hypersensitivity. Such
  advancement and innovation by CROs is expected to
  favor growth of biomarkers market in the near
  future.

4
The Global Biomarkers Market Value (US Mn), By
Region (2017)
5
Market Drivers

• Increasing application of diagnostic application
  is expected to fuel growth of the global
  biomarkers market
• Increasing application and awareness about
  biomarker tests is expected to be a major factor
  for growth of the market. Biomarkers are used for
  diagnostics and early detection of specific
  diseases over the conventional diagnostics
  methods. Furthermore, biomarkers such as BRCA1,
  indicates whether an individual has an increased
  likelihood of developing cancer. Biomarkers are
  also applied to a wide variety of therapeutic
  areas, which include neurological diseases,
  metabolic disorders, immune deregulation and
  oncology to treat various disease such as TMI,
  cancer, Alzheimer diagnosis. Biomarkers are also
  used to detect ABO haemolytic disease of new
  born, Huntington disease, and hereditary
  haemochromatosis, and cystic fibrosis.
• Furthermore, biomarkers are used to detect
  disorder related to chromosome structure such as,
  Turner syndrome, Down syndrome, patau syndrome,
  Edwardss syndrome, and others, which has led to
  increasing demand for biomarkers.

6

• Increasing demand for precision medicine to drive
  the growth of the global biomarkers market
• North America accounts for the largest share in
  the global biomarkers market and this is
  attributed to adoption of precision medicine and
  growing prevalence of cancer in the region.
  According to the National Cancer Institute, 2016,
  it was estimated that 16.8 million new cases of
  cancer were diagnosed in the U.S., with around
  595,690 deaths from cancer disease. The number of
  people suffering from cancer is expected to rise
  to 19 million by 2024, which supports increasing
  demand for precision medicine.
• Furthermore, the U.S. government in 2015
  announced the launch of Precision Medicine
  Initiative that aimed to revolutionize the
  treatment to improve health, as precision
  medicine is an innovative approach to offer
  tailored treatment. Precision Medicine Initiative
  have led to development of novel drugs and new
  treatments, tailored for specific characteristic
  such as persons genetic makeup or genetic
  profile of an individual tumor that helps to
  transform the way of treatment. This also favors
  growth of the biomarkers market in the near
  future. As for the development of precision
  medicine, it is essential to identify biomarkers.

7
Key Development

• Key players are involved in new product launches
  to cater to increasing demand for biomarkers. For
  instance, in 2016 Abbott Laboratories launched
  Point-of-Care i-STAT Alinity, an innovative,
  handheld blood testing platform.

8
Key Players

• Some of the other key players in biomarkers
  market include Medtronic plc, BG Medicine, Inc.,
  F. Hoffmann-La Roche Ltd., Seimens Healthnineers,
  Nexus-DX, Qiagen N.V., and Lifesign LLC.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/biomarkers-market-1530

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

12

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/